Burling Wealth Partners LLC Sells 2,810 Shares of CME Group Inc. (NASDAQ:CME)

Burling Wealth Partners LLC decreased its position in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 11.2% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 22,306 shares of the financial services provider's stock after selling 2,810 shares during the quarter. CME Group comprises approximately 1.2% of Burling Wealth Partners LLC's investment portfolio, making the stock its 20th largest position. Burling Wealth Partners LLC's holdings in CME Group were worth $5,918,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in CME. Heartland Bank & Trust Co acquired a new stake in CME Group in the 1st quarter valued at $377,000. Catalyst Capital Advisors LLC boosted its holdings in CME Group by 256.9% during the 1st quarter. Catalyst Capital Advisors LLC now owns 3,662 shares of the financial services provider's stock worth $971,000 after acquiring an additional 2,636 shares during the last quarter. OMNI 360 Wealth Inc. purchased a new position in CME Group during the 1st quarter worth $367,000. Fulcrum Equity Management purchased a new position in CME Group during the 1st quarter worth $258,000. Finally, Aspire Growth Partners LLC purchased a new position in CME Group during the 4th quarter worth $548,000. Institutional investors own 87.75% of the company's stock.

Insider Transactions at CME Group

In related news, Director Phyllis M. Lockett sold 1,060 shares of the firm's stock in a transaction on Monday, May 19th. The stock was sold at an average price of $277.88, for a total value of $294,552.80. Following the completion of the sale, the director owned 3,108 shares of the company's stock, valued at $863,651.04. This trade represents a 25.43% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Charles P. Carey sold 3,000 shares of the firm's stock in a transaction on Thursday, May 15th. The stock was sold at an average price of $272.56, for a total value of $817,680.00. Following the completion of the sale, the director directly owned 5,400 shares of the company's stock, valued at $1,471,824. The trade was a 35.71% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 13,400 shares of company stock valued at $3,680,610. 0.30% of the stock is currently owned by insiders.

CME Group Price Performance

Shares of CME Group stock traded down $3.12 on Friday, reaching $274.70. The stock had a trading volume of 2,197,249 shares, compared to its average volume of 2,183,774. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The business's 50 day moving average is $275.89 and its two-hundred day moving average is $260.85. The company has a market cap of $98.99 billion, a P/E ratio of 27.64, a price-to-earnings-growth ratio of 4.81 and a beta of 0.44. CME Group Inc. has a 1 year low of $193.25 and a 1 year high of $290.79.

CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share for the quarter, topping the consensus estimate of $2.61 by $0.19. The company had revenue of $1.64 billion for the quarter, compared to analysts' expectations of $1.56 billion. CME Group had a net margin of 57.71% and a return on equity of 14.03%. CME Group's revenue for the quarter was up 10.4% compared to the same quarter last year. During the same period in the prior year, the business earned $2.50 earnings per share. As a group, research analysts anticipate that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, June 25th. Stockholders of record on Monday, June 9th were issued a $1.25 dividend. This represents a $5.00 annualized dividend and a dividend yield of 1.82%. The ex-dividend date of this dividend was Monday, June 9th. CME Group's dividend payout ratio is 50.30%.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on the stock. Morgan Stanley lifted their price objective on shares of CME Group from $301.00 to $304.00 and gave the stock an "overweight" rating in a report on Thursday, April 24th. Keefe, Bruyette & Woods lifted their price objective on shares of CME Group from $265.00 to $273.00 and gave the stock a "market perform" rating in a report on Thursday, April 24th. Wall Street Zen downgraded shares of CME Group from a "hold" rating to a "sell" rating in a report on Sunday, July 13th. Bank of America upped their price objective on shares of CME Group from $200.00 to $219.00 and gave the company an "underperform" rating in a report on Wednesday, April 2nd. Finally, Oppenheimer upped their price objective on shares of CME Group from $282.00 to $300.00 and gave the company an "outperform" rating in a report on Wednesday, June 4th. Four equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and five have issued a buy rating to the company. According to data from MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $261.80.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.